Price History
Navin Fluorine's long-term growth prospects have caught the eye of Prabhudas Lilladher, who recommends buying and sets a target price of Rs 7,489. Key factors include the upcoming R32 capacity starting in Q3 FY2026-2027, and the delayed partnership with Chemours, which could potentially increase capital expenditure by 10 times in Phase 2.
Navin Fluorine International reaches an all-time high of ₹7,253.8 on May 25, 2026, demonstrating robust financial and technical performance. This growth suggests a promising outlook for the company's future.
Navin Fluorine International executed a significant block trade of approximately INR 34.9 crore, with each share trading at INR 7,075. This represents a substantial deal involving around 49,268 shares.
Navin Fluorine is planning to expand its HFC production capacity by up to 15,000 MTPA by Q3 of FY27, anticipating a potential annual revenue increase between Rs. 600-825 crores.
Navin Fluorine International will host an investor presentation for their Q4 FY26 results on April 29, 2026. Their stock symbols on the BSE and NSE are 532504 and NAVINFLUOR respectively, for interested investors to track.
China's intensified regulations are inadvertently aiding chemical companies in India, notably Aarti, SRF, and Navin. This is due to reduced competition in the market, leading to improved pricing and profit margins.
Bayer's drugs Nubeqa and Keredia are experiencing significant growth, boosting the Contract Development and Manufacturing Organization (CDMO) sector. Notably, Navin Fluorine and Aarti Drugs play crucial roles as CDMO partners for Bayer, with their contributions through Acutaas.
Navin Fluorine has announced a final dividend of ₹8.60 per share for the financial year 2025-26. Keep in mind that this dividend is taxable, with tax deduction rates depending on your category, and you may need specific documents to qualify for any exemptions.
Navin Fluorine's impressive performance can be attributed to robust execution and favorable pricing conditions, enhancing the company's growth prospects.
Navin Fluorine achieves a new record high of Rs 7,208.5 on April 30, 2026, signifying robust growth within the specialty chemicals industry.
Navin Fluorine's Q4 results were noteworthy, with both Jefferies and DAM Capital maintaining a bullish outlook. They have set target prices of ₹8,385 and ₹7,769 respectively, anticipating a 24% EPS CAGR for FY26-28. The impressive performance was seen across various segments, including HPP and CDMO.
Navin Fluorine executed a significant block deal on the NSE, worth approximately INR 51.34 crores for 78,241 shares, with each share traded at INR 6,561.50.
Navin Fluorine has reported a loss of share certificates according to the Financial Express. Affected shareholders have 15 days to file claims with KFIN Technologies for replacement certificates.